Trademark: 88228691
Word
LYELL
Status
Registered
Status Code
700
Status Date
Tuesday, October 31, 2023
Serial Number
88228691
Registration Number
7207833
Registration Date
Tuesday, October 31, 2023
Mark Type
4000
Filing Date
Thursday, December 13, 2018
Published for Opposition
Tuesday, June 30, 2020

Trademark Owner History
Lyell Immunopharma, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
42 Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific research

Trademark Events
Oct 31, 2023
Notice Of Registration Confirmation Emailed
Oct 31, 2023
Registered-Principal Register
Sep 28, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 27, 2023
Allowed Principal Register - Sou Accepted
Aug 19, 2023
Statement Of Use Processing Complete
Aug 18, 2023
Use Amendment Filed
Aug 18, 2023
Teas Statement Of Use Received
Feb 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2023
Sou Extension 5 Granted
Jan 27, 2023
Sou Extension 5 Filed
Feb 13, 2023
Case Assigned To Intent To Use Paralegal
Jan 27, 2023
Sou Teas Extension Received
Jul 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 28, 2022
Sou Extension 4 Granted
Jul 28, 2022
Sou Extension 4 Filed
Jul 28, 2022
Sou Teas Extension Received
Jan 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 19, 2022
Sou Extension 3 Granted
Jan 19, 2022
Sou Extension 3 Filed
Jan 19, 2022
Sou Teas Extension Received
Oct 1, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 1, 2021
Teas Change Of Correspondence Received
Oct 1, 2021
Teas Change Of Owner Address Received
Aug 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2021
Sou Extension 2 Granted
Aug 5, 2021
Sou Extension 2 Filed
Aug 5, 2021
Sou Teas Extension Received
Jan 5, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 31, 2020
Sou Extension 1 Granted
Dec 31, 2020
Sou Extension 1 Filed
Dec 31, 2020
Sou Teas Extension Received
Aug 25, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 30, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 30, 2020
Published For Opposition
Jun 10, 2020
Notification Of Notice Of Publication E-Mailed
May 12, 2020
Withdrawn From Pub - Og Review Query
Apr 27, 2020
Approved For Pub - Principal Register
Apr 24, 2020
Teas/Email Correspondence Entered
Apr 24, 2020
Correspondence Received In Law Office
Apr 24, 2020
Teas Request For Reconsideration Received
Apr 15, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 15, 2020
Teas Change Of Correspondence Received
Apr 15, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 15, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 15, 2020
Teas Change Of Owner Address Received
Oct 31, 2019
Notification Of Final Refusal Emailed
Oct 31, 2019
Final Refusal E-Mailed
Oct 31, 2019
Final Refusal Written
Oct 8, 2019
Teas/Email Correspondence Entered
Oct 8, 2019
Correspondence Received In Law Office
Oct 7, 2019
Assigned To Lie
Oct 1, 2019
Notice Of Revival - E-Mailed
Oct 1, 2019
Teas Response To Office Action Received
Oct 1, 2019
Petition To Revive-Granted
Oct 1, 2019
Teas Petition To Revive Received
Mar 19, 2019
Notification Of Non-Final Action E-Mailed
Mar 19, 2019
Non-Final Action E-Mailed
Mar 19, 2019
Non-Final Action Written
Mar 12, 2019
Assigned To Examiner
Jan 5, 2019
New Application Office Supplied Data Entered
Dec 17, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24